These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 10929761)

  • 41. Novel bicistronic retroviral vector expressing gamma-glutamylcysteine synthetase and the multidrug resistance protein 1 (MRP1) protects cells from MRP1-effluxed drugs and alkylating agents.
    Rappa G; Lorico A; Hildinger M; Fodstad Ø; Baum C
    Hum Gene Ther; 2001 Sep; 12(14):1785-96. PubMed ID: 11560771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generation of mammalian cells stably expressing multiple genes at predetermined levels.
    Liu X; Constantinescu SN; Sun Y; Bogan JS; Hirsch D; Weinberg RA; Lodish HF
    Anal Biochem; 2000 Apr; 280(1):20-8. PubMed ID: 10805516
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector.
    Halene S; Wang L; Cooper RM; Bockstoce DC; Robbins PB; Kohn DB
    Blood; 1999 Nov; 94(10):3349-57. PubMed ID: 10552944
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeted expression of two proteins in neural retina using self-inactivating, insulated lentiviral vectors carrying two internal independent promoters.
    Semple-Rowland SL; Eccles KS; Humberstone EJ
    Mol Vis; 2007 Oct; 13():2001-11. PubMed ID: 17982424
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression.
    Couture LA; Mullen CA; Morgan RA
    Hum Gene Ther; 1994 Jun; 5(6):667-77. PubMed ID: 7948129
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparative evaluation of gene transfer into blood cells using the same retroviral backbone for independent expression of the EGFP and deltaLNGFR marker genes.
    Giaretta I; Madeo D; Bonaguro R; Cappellari A; Rodeghiero F; Giorgio P
    Haematologica; 2000 Jul; 85(7):680-9. PubMed ID: 10897118
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-titer retroviral vectors containing the enhanced green fluorescent protein gene for efficient expression in hematopoietic cells.
    Limón A; Briones J; Puig T; Carmona M; Fornas O; Cancelas JA; Nadal M; García J; Rueda F; Barquinero J
    Blood; 1997 Nov; 90(9):3316-21. PubMed ID: 9345013
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gene transfer to hepatocellular carcinoma: transduction efficacy and transgene expression kinetics by using retroviral and lentiviral vectors.
    Gerolami R; Uch R; Jordier F; Chapel S; Bagnis C; Bréchot C; Mannoni P
    Cancer Gene Ther; 2000 Sep; 7(9):1286-92. PubMed ID: 11023202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transduction efficiency of pantropic retroviral vectors is controlled by the envelope plasmid to vector plasmid ratio.
    Chen Y; Miller WM; Aiyar A
    Biotechnol Prog; 2005; 21(1):274-82. PubMed ID: 15903266
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lentiviral Vectors Mediate Long-Term and High Efficiency Transgene Expression in HEK 293T cells.
    Mao Y; Yan R; Li A; Zhang Y; Li J; Du H; Chen B; Wei W; Zhang Y; Sumners C; Zheng H; Li H
    Int J Med Sci; 2015; 12(5):407-15. PubMed ID: 26005375
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Topological constraints governing the use of the chicken HS4 chromatin insulator in oncoretrovirus vectors.
    Yannaki E; Tubb J; Aker M; Stamatoyannopoulos G; Emery DW
    Mol Ther; 2002 May; 5(5 Pt 1):589-98. PubMed ID: 11991750
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retroviral vectors encoding ADA regulatory locus control region provide enhanced T-cell-specific transgene expression.
    Trinh AT; Ball BG; Weber E; Gallaher TK; Gluzman-Poltorak Z; Anderson F; Basile LA
    Genet Vaccines Ther; 2009 Dec; 7():13. PubMed ID: 20042112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcriptional targeting of lentiviral vectors by long terminal repeat enhancer replacement.
    Lotti F; Menguzzato E; Rossi C; Naldini L; Ailles L; Mavilio F; Ferrari G
    J Virol; 2002 Apr; 76(8):3996-4007. PubMed ID: 11907239
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Construction and characterization of bicistronic retroviral vectors encoding the multidrug transporter and beta-galactosidase or green fluorescent protein.
    Aran JM; Gottesman MM; Pastan I
    Cancer Gene Ther; 1998; 5(4):195-206. PubMed ID: 9694071
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of multigene and regulated lentivirus vectors.
    Reiser J; Lai Z; Zhang XY; Brady RO
    J Virol; 2000 Nov; 74(22):10589-99. PubMed ID: 11044103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner.
    Xia X; Zhang Y; Zieth CR; Zhang SC
    Stem Cells Dev; 2007 Feb; 16(1):167-76. PubMed ID: 17348812
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FLT3 ligand preserves the uncommitted CD34+CD38- progenitor cells during cytokine prestimulation for retroviral transduction.
    Nielsen SD; Husemoen LL; Sørensen TU; Gram GJ; Hansen JE
    J Hematother Stem Cell Res; 2000 Oct; 9(5):695-701. PubMed ID: 11091493
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficient adenoviral vector transduction of human hematopoietic SCID-repopulating and long-term culture-initiating cells.
    Fan X; Brun A; Segrén S; Jacobsen SE; Karlsson S
    Hum Gene Ther; 2000 Jun; 11(9):1313-27. PubMed ID: 10890741
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effects of Different Promoters and
    Li Q; Wang XY; Zhao CP; Tian ZW; Xu DH; Wang TY; Zhang JH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):18-23. PubMed ID: 29737083
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced transgene expression in primitive hematopoietic progenitor cells and embryonic stem cells efficiently transduced by optimized retroviral hybrid vectors.
    Ketteler R; Glaser S; Sandra O; Martens UM; Klingmüller U
    Gene Ther; 2002 Apr; 9(8):477-87. PubMed ID: 11948372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.